GlassScriptPhysician profile
Gary S Goldberg
NPI 1013995034
$2,261.02
in general payments reported to CMS, 2019-2025
31 companies · $343 in 2025
The $343 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $132 · 2021: $312 · 2022: $441 · 2023: $381 · 2024: $396 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,119.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $308.44 | 2019-2025 | Speedicath |
| Teleflex LLC | $274.28 | 2021-2025 | Urolift, Barrigel |
| 180 Medical, INC. | $173.32 | 2022-2025 | Cure Catheter, Gentlecath, Cure Ultra Catheter |
| Axonics, INC. | $159.56 | 2020-2024 | Axonics |
| Antares Pharma, INC. | $135.17 | 2019-2024 | Xyosted, Nocdurna, Tlando |
| Progenics Pharmaceuticals, INC. | $131.62 | 2021-2025 | Pylarify |
| Abbvie INC. | $127.01 | 2019-2025 | |
| Astellas Pharma US INC | $89.01 | 2019-2024 | Xtandi |
| Accord Healthcare, INC. | $79.01 | 2022-2024 | |
| Convatec INC. | $61.57 | 2022-2023 | |
| Laborie Medical Technologies Corp. | $61.49 | 2021-2025 | Optilume Bph Drug Coated Balloon Catheter, Eclipse |
| Dendreon Pharmaceuticals LLC | $58.28 | 2019-2025 | Provenge |
| Blue Earth Diagnostics | $57.30 | 2022-2025 | Posluma |
| Endo Pharmaceuticals INC. | $53.67 | 2019 | |
| Myovant Sciences INC. | $48.01 | 2021-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $45.09 | 2022-2025 | Axonics |
| Neotract INC. | $43.17 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $41.75 | 2023-2025 | |
| Medtronic, INC. | $37.47 | 2023 | Interstim |
| Verity Pharmaceuticals INC. | $36.69 | 2025 | Trelstar |
| Janssen Biotech, INC. | $34.63 | 2023-2025 | Erleada, Akeega |
| C. R. Bard, INC. & Subsidiaries | $32.43 | 2020 | |
| Photocure INC | $28.71 | 2023 | Cysview |
| Tolmar, INC. | $27.66 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $20.63 | 2025 | Lynparza |
| Hollister Incorporated | $20.03 | 2019 | |
| Olympus America INC. | $19.64 | 2021 | |
| Sumitomo Pharma America, INC. | $16.35 | 2024 | Gemtesa |
| Abc Home Medical Supply, INC. | $15.36 | 2025 | |
| Merck Sharp & Dohme LLC | $12.08 | 2021 | |
| Clinical Technology, INC | $11.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Goldberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.